NCT05153226 GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05025098 Precision Therapy Versus Standard Therapy in AML and MDS in Elderly Status RECRUITING Phase PHASE2
NCT05024877 Hetrombopag for Low/Intermediate-1 Risk MDS With Thrombocytopenia Status UNKNOWN Phase PHASE2/PHASE3
NCT04901416 Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDS Status COMPLETED Phase PHASE1
NCT04857645 ASTX727 and Donor Lymphocyte Infusions After Allogenic Stem Cell Transplantation in Very High Risk MDS or AML Patients Status COMPLETED Phase PHASE2
NCT04806906 Pilot Study of CC 486 (Oral Azacitidine) Plus BSC as Maintenance After sc Azacitidine in Elderly HR-IPSS-R MDS Patients Status COMPLETED Phase PHASE2
NCT04749355 Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS Status UNKNOWN Phase PHASE2
NCT04730258 A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04644016 Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders Status RECRUITING Phase PHASE2
NCT04638309 APR-548 in Combination With Azacitidine for the Treatment of TP53 Myelodysplastic Syndromes (MDS) Status TERMINATED Phase PHASE1
NCT04623944 NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04573686 Prognostic Value of Serum Erythropoietin Level,Ferritin Level and Fibrinogen in Adult Low Risk MDS Status UNKNOWN Phase N/A
NCT04547049 A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04511975 A Study Evaluating the Safety and Efficacy of IBI188 in Combination With AZA in Subjects With Newly Diagnosed MDS Status SUSPENDED Phase PHASE1
NCT04443751 A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE1
NCT04358393 A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS Status RECRUITING Phase PHASE1/PHASE2
NCT04187105 BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) Status RECRUITING Phase PHASE2